Oct. 10, 2017
A person struggles, then panics, gasping for air but unable to inhale — as if “I were trying to breathe air underwater” or “an elephant is sitting on my chest.” Those are the most common...Read More
Oct. 6, 2017
‘You know you’re doing something good for society’ During his first few years at UNC, Michael Hall ’76 spent a lot of time in the biology lab, but he also logged many rounds on...Read More
Sept. 18, 2017
Joseph DeSimone, whose scientific career has revolved around creating technology with real-world applications, has been named the recipient of the 22nd Heinz Award in the category of Technology, the Economy and Employment. The award comes...Read More
UNC researchers will use an $11.3 million grant to explore using nanoparticles to create cancer vaccines and improve delivery of cancer-fighting drugs and patients’ responses to them.
The five-year grant announced Monday is the third in a series of awards that the University has won from the National Cancer Institute for cancer nanotechnology research. It will fund researchers with the Carolina Center of Cancer Nanotechnology Excellence, an institute-funded collaboration between the University and the UNC Lineberger Comprehensive Cancer Center.
“UNC-Chapel Hill has emerged as a leader in nanotechnology in the last 10 years,” said Leaf Huang, a UNC Lineberger member, Fred Eshelman Distinguished Professor and interim chair of the UNC Eshelman School of Pharmacy Division of Molecular Therapeutics, and the co-leader of the cancer nanotechnology center. “This grant is a testament to the quality of our research in using nanotechnology to continue to find innovative ways to fight cancer.”
The grant will fund four studies of nanotechnology in fighting cancer: